Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00119743
First received: July 6, 2005
Last updated: September 14, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2004
  Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)